NVAX logo

Novavax Inc. (NVAX)

$7.83

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on NVAX

Market cap

$1.29B

EPS

-0.41

P/E ratio

--

Price to sales

2.19

Dividend yield

--

Beta

2.427091

Price on NVAX

Previous close

$7.91

Today's open

$7.83

Day's range

$7.72 - $7.91

52 week range

$6.20 - $11.97

Profile about NVAX

CEO

JOHN C. JACOBS

Employees

952

Headquarters

Gaithersburg, MD

Exchange

Nasdaq Global Select

Shares outstanding

164438119

Issue type

Common Stock

NVAX industries and sectors

Healthcare

Biotechnology & Life Sciences

News on NVAX

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.

news source

Zacks Investment Research • Jul 22, 2026

news preview

Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to Note

Novavax (NVAX) reached $7.88 at the closing of the latest trading day, reflecting a -4.02% change compared to its last close.

news source

Zacks Investment Research • Jul 20, 2026

news preview

Novavax (NVAX) Stock Sinks As Market Gains: Here's Why

In the latest trading session, Novavax (NVAX) closed at $8.42, marking a -5.5% move from the previous day.

news source

Zacks Investment Research • Jul 14, 2026

news preview

Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights

Novavax (NVAX) concluded the recent trading session at $9.35, signifying a -1.16% move from its prior day's close.

news source

Zacks Investment Research • Jul 8, 2026

news preview

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.

news source

Zacks Investment Research • Jul 7, 2026

news preview

Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM

RALEIGH, N.C., June 24, 2026 (GLOBE NEWSWIRE) -- Shah Capital, the largest shareholder of Novavax, today commented on yesterday's announced voting results from Novavax's June 18th 2026 Annual Meeting of Stockholders.

news source

GlobeNewsWire • Jun 24, 2026

news preview

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

news source

Zacks Investment Research • Jun 23, 2026

news preview

Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know

Novavax (NVAX) closed the most recent trading day at $9.13, moving 3.89% from the previous trading session.

news source

Zacks Investment Research • Jun 18, 2026

news preview

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is jumping again.

news source

24/7 Wall Street • Jun 16, 2026

news preview

Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade

Novavax (NVAX) closed the most recent trading day at $8.88, moving 1.66% from the previous trading session.

news source

Zacks Investment Research • Jun 12, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Novavax Inc.

Open an M1 investment account to buy and sell Novavax Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in NVAX on M1